Uscom Share Price and Company Fundamentals
Last traded: Today at 3:44 AM
Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. It offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. The company provides Ventitest, a ventilator testing device; Ventitest sensor to test lung function; and The SpiroSonic AIR, a digital home care spirometer which feeds digital lung function signals through a phone app. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.
|Primary activities||Developer and manufacturer of premium cardiovascular devices with two practice-leading technologies - Uscom 1A & Uscom BP+, both being marketed into global distribution networks.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||66 Clarence Street Suite 2 Level 8 Sydney NSW 2000 Australia|
|Phone / Fax||61 2 9247 4144 / 61 2 9247 8157|
|Share registry||BOARDROOM PTY LIMITED|
Uscom does not pay dividends.
As of May 2021, following are the company executives and directors listed on Uscom.
|Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR||Founder, Exec. Chairman, CEO & Chief Scientist||67||275.17k|
|Mr. Brett Crowley B.Com., C.A., BCom, DipLaw, CA||Company Sec. & Non-Exec. Director||63||38.28k|
|Mr. Nicholas Schicht||Gen. Mang.||54||213.16k|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Uscom is 20.78M and its enterprise value is 21.54M. The enterprise value to revenue ratio of UCM is 3.56.
Companies similar to Uscom (UCM)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Uscom (ASX:UCM) Frequently Asked Questions
1. What is Uscom's Stock Symbol?
Uscom trades on ASX under the ticker symbol "UCM".
2. What is Uscom's stock price today?
One share of UCM stock can currently be purchased for approximately $0.135.
3. How can I contact Uscom?
Uscom's mailing address is 66 Clarence Street Suite 2 Level 8 Sydney NSW 2000 Australia. The company can be reached via phone at 61 2 9247 4144.
4. What is Uscom's official website?
The official website of Uscom is http://www.uscom.com.au.
5. Which share registry manages Uscom's stock?
Uscom's stock is managed by BOARDROOM PTY LIMITED.